FDA Calls Safety Of Aleve Into Question
BIRMINGHAM, Ala. -- After reviewing an Alzheimerâs study, the Food and Drug Administration has said that the popular over-the-counter painkiller Aleve could increase the risk for heart attacks and strokes.
For someone whose company is facing a federal criminal investigation, hundreds of lawsuits that could cost billions, and outrage in the medical world, Ray Gilmartin is putting on a brave face.